Why $AYRO Ayro, Inc. Surged yesterday?
Why 
AYRO Anchiano Therapeutics Surged yesterday?
Thanks to some news in January,AYRO stock is racing higher. So what was that news? And what else do you need to know?
AYRO is captivating investors thanks to its $20 Million Registered Direct Offering with Two Existing Investors news on January 25.
Announced that it has entered into definitive agreements with two existing institutional investors for the purchase and sale of 3,333,334 shares of the Company’s common stock, at a purchase price of $6.00 per share, in a registered direct offering. AYRO has also agreed to issue to the investors unregistered warrants to acquire 3,333,334 shares of common stock at $6.93 per share, exercisable six months after the closing and terminating two and a half years after the date of issuance.
finance.yahoo.com/news/ayro-announces-20-million-registered-140000057.html
AYRO Anchiano Therapeutics Surged yesterday?Thanks to some news in January,
AYRO stock is racing higher. So what was that news? And what else do you need to know?AYRO is captivating investors thanks to its $20 Million Registered Direct Offering with Two Existing Investors news on January 25.Announced that it has entered into definitive agreements with two existing institutional investors for the purchase and sale of 3,333,334 shares of the Company’s common stock, at a purchase price of $6.00 per share, in a registered direct offering. AYRO has also agreed to issue to the investors unregistered warrants to acquire 3,333,334 shares of common stock at $6.93 per share, exercisable six months after the closing and terminating two and a half years after the date of issuance.
finance.yahoo.com/news/ayro-announces-20-million-registered-140000057.html
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.